Flora S (2020) Biological warfare agents: history and modern-day relevance. Handbook on biological warfare preparedness. Elsevier, Amsterdam, pp 1–11. https://doi.org/10.1016/B978-0-12-812026-2.00001-3
Sunagar R et al (2016) Tularemia vaccine development: paralysis or progress? Vaccine (Auckl) 6:9–23. https://doi.org/10.2147/vdt.S85545
Article CAS PubMed Google Scholar
Oyston PC, Quarry JE (2005) Tularemia vaccine: past, present and future. Antonie Van Leeuwenhoek 87(4):277–281. https://doi.org/10.1016/B978-0-12-812026-2.00001-3
Maurin M et al (2024) Tularemia treatment: experimental and clinical data. Front Microbiol 14:1348323. https://doi.org/10.3389/fmicb.2023.1348323
Article PubMed PubMed Central Google Scholar
Maurin M, Gyuranecz M (2016) Tularaemia: clinical aspects in Europe. Lancet Infect Dis 16(1):113–124. https://doi.org/10.1016/S1473-3099(15)00355-2
Bröms JE, Sjöstedt A, Lavander M (2010) The role of the Francisella tularensis pathogenicity island in type VI secretion, intracellular survival, and modulation of host cell signaling. Front Microbiol 1:136. https://doi.org/10.3389/fmicb.2010.00136
Article PubMed PubMed Central Google Scholar
Hood AM (1977) Virulence factors of Francisella tularensis. Epidemiol Infect 79(1):47–60. https://doi.org/10.1017/s0022172400052840
Freudenberger Catanzaro KC, Inzana TJ (2020) The Francisella tularensis polysaccharides: what is the real capsule? Microbiol Mol Biol Rev. https://doi.org/10.1128/mmbr.00065-19
Article PubMed PubMed Central Google Scholar
Gunn JS, Ernst RK (2007) The structure and function of Francisella lipopolysaccharide. Ann N Y Acad Sci 1105(1):202–218. https://doi.org/10.1196/annals.1409.006
Article CAS PubMed PubMed Central Google Scholar
Barry EM, Cole LE, Santiago AE (2009) Vaccines against tularemia. Hum Vaccin 5(12):832–838. https://doi.org/10.4161/hv.10297
Article CAS PubMed Google Scholar
Fulop M, Manchee R, Titball R (1995) Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. Vaccine 13(13):1220–1225. https://doi.org/10.1016/0264-410x(95)00062-6
Article CAS PubMed Google Scholar
Sjöstedt A et al (1992) The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis. Microb Pathog 13(3):243–249. https://doi.org/10.1016/0882-4010(92)90025-j
Pavkova I et al (2021) Francisella tularensis outer membrane vesicles participate in the early phase of interaction with macrophages. Front Microbiol 12:748706. https://doi.org/10.3389/fmicb.2021.748706
Article PubMed PubMed Central Google Scholar
Holland IB, Schmitt L, Young J (2005) Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway (review). Mol Membr Biol 22(1–2):29–39. https://doi.org/10.1080/09687860500042013
Article CAS PubMed Google Scholar
Eicher T et al (2012) Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc Natl Acad Sci U S A 109(15):5687–5692. https://doi.org/10.1073/pnas.1114944109
Article PubMed PubMed Central Google Scholar
Gil H et al (2006) Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci U S A 103(34):12897–12902. https://doi.org/10.1073/pnas.0602582103
Article CAS PubMed PubMed Central Google Scholar
Kadzhaev K et al (2009) Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS ONE 4(5):e5463. https://doi.org/10.1371/journal.pone.0005463
Article CAS PubMed PubMed Central Google Scholar
Forslund AL et al (2010) The type IV pilin, PilA, is required for full virulence of Francisella tularensis subspecies tularensis. BMC Microbiol 10:227. https://doi.org/10.1186/1471-2180-10-227
Article CAS PubMed PubMed Central Google Scholar
Clemens DL, Lee BY, Horwitz MA (2018) The Francisella type VI secretion system. Front Cell Infect Microbiol 8:121. https://doi.org/10.3389/fcimb.2018.00121
Article CAS PubMed PubMed Central Google Scholar
Basler M (2015) Type VI secretion system: secretion by a contractile nanomachine. Philos Trans R Soc Lond B Biol Sci. https://doi.org/10.1098/rstb.2015.0021
Article PubMed PubMed Central Google Scholar
Cianfanelli FR, Monlezun L, Coulthurst SJ (2016) Aim, load, fire: the type VI secretion system, a bacterial nanoweapon. Trends Microbiol 24(1):51–62. https://doi.org/10.1016/j.tim.2015.10.005
Article CAS PubMed Google Scholar
Hood RD, Peterson SB, Mougous JD (2017) From Striking Out to Striking Gold: Discovering that Type VI Secretion Targets Bacteria. Cell Host Microbe 21(3):286–289. https://doi.org/10.1016/j.chom.2017.02.001
Article CAS PubMed PubMed Central Google Scholar
Del Tordello E et al (2016) Type VI secretion system sheaths as nanoparticles for antigen display. Proc Natl Acad Sci U S A 113(11):3042–3047. https://doi.org/10.1073/pnas.1524290113
Article CAS PubMed PubMed Central Google Scholar
Cuccui J et al (2013) Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol 3(5):130002. https://doi.org/10.1098/rsob.130002
Article CAS PubMed PubMed Central Google Scholar
Brodmann M et al (2017) Francisella requires dynamic type VI secretion system and ClpB to deliver effectors for phagosomal escape. Nat Commun 8:15853. https://doi.org/10.1038/ncomms15853
Article CAS PubMed PubMed Central Google Scholar
Ludu JS et al (2008) The Francisella pathogenicity island protein PdpD is required for full virulence and associates with homologues of the type VI secretion system. J Bacteriol 190(13):4584–4595. https://doi.org/10.1128/JB.00198-08
Article CAS PubMed PubMed Central Google Scholar
Ramond E et al (2012) Proteins involved in Francisella tularensis survival and replication inside macrophages. Future Microbiol 7(11):1255–1268. https://doi.org/10.2217/fmb.12.103
Article CAS PubMed Google Scholar
Wawszczak M, Banaszczak B, Rastawicki W (2022) Tularaemia—a diagnostic challenge. Ann Agric Environ Med 29(1):12–21. https://doi.org/10.26444/aaem/139242
Caspar Y, Maurin M (2017) Francisella tularensis susceptibility to antibiotics: a comprehensive review of the data obtained in VITRO and in animal models. Front Cell Infect Microbiol 7:122. https://doi.org/10.3389/fcimb.2017.00122
Article CAS PubMed PubMed Central Google Scholar
Marohn ME, Barry EM (2013) Live attenuated tularemia vaccines: recent developments and future goals. Vaccine 31(35):3485–3491. https://doi.org/10.1016/j.vaccine.2013.05.096
Article CAS PubMed PubMed Central Google Scholar
Burke DS (1977) Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 135(1):55–60. https://doi.org/10.1093/infdis/135.1.55
Article CAS PubMed Google Scholar
El Sahly HM et al (2009) Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine 27(36):4905–4911. https://doi.org/10.1016/j.vaccine.2009.06.036
Article CAS PubMed PubMed Central Google Scholar
Wu TH et al (2005) Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun 73(5):2644–2654. https://doi.org/10.1128/iai.73.5.2644-2654.2005
Article CAS PubMed PubMed Central Google Scholar
Wayne Conlan J et al (2005) Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects m
留言 (0)